PRE 14A

BIOTIME INC PRE 14A 3-5-2013

Company: Lineage Cell Therapeutics, Inc.
Filed: March 5, 2013
Period of Report: March 5, 2013
Accession Number: 0001140361-13-010697

View Document ↗ View on SEC.gov ↗